Belgium· BE-AMP-SAM664536-00

Illuccix 25 µg

A gallium (68ga) gozetotide product containing gozetotide, registered in Belgium by Telix Innovations. The same ATC class is registered in 11 of our 19 countries.

ATC V09IX14

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIlluccix 25 µgATCV09IX14REGISTER NO.BE-AMP-SAM664536-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Gallium (68ga) gozetotide is registered in 11 of 19 countries.

Countries holding a registration under ATC V09IX14 (gallium (68ga) gozetotide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Gallium (68ga) gozetotide · ATC V09IX14

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Gozetotide
Manufacturer
Telix Innovations
Country
Belgium (BE)
ATC code
V09IX14
ATC class
Gallium (68Ga) gozetotide
Defined daily dose
140 MBq, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    4961892
  • be_apb
    4960910

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Gallium (68ga) gozetotide in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gallium (68ga) gozetotide products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Illuccix, Isoprotrace
  • Cyprus · Illuccix, Isoprotrace
  • Czechia · Illuccix, Isoprotrace
  • Germany · Illuccix, Isoprotrace
  • Denmark · Illuccix, Isoprotrace
  • Spain · Illuccix, Isoprotrace
  • Finland · Illuccix, Isoprotrace
  • France · Illuccix, Isoprotrace
  • United Kingdom (Northern Ireland) · Illuccix, Isoprotrace
  • Greece · Illuccix, Isoprotrace
  • Ireland · Illuccix
  • Iceland · Locametz
  • Italy · Illuccix, Viewprost
  • Liechtenstein · Locametz
  • Luxembourg · Illuccix, Isoprotrace
  • Malta · Illuccix, Isoprotrace
  • Netherlands · Illuccix, Isoprotrace
  • Norway · Illuccix, Isoprotrace
  • Poland · Psmatrace
  • Portugal · Illuccix, Isoprotrace
  • Sweden · Illuccix, Isoprotrace
  • Slovakia · Illuccix, Isoprotrace

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/35000cee-a520-42dc-b56f-0b8f23de1ff9
GET /v1/drugs/35000cee-a520-42dc-b56f-0b8f23de1ff9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit for radiopharmaceutical preparation",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Illuccix 25 µg",
  "name_fr": "Illuccix 25 µg",
  "name_nl": "Illuccix 25 µg",
  "amp_code": "SAM664536-00",
  "strengths": [
    "25.0000",
    "25.0000",
    "0.1500",
    "0.1500"
  ],
  "pack_count": 2,
  "substances": [
    "Gozetotide",
    "Sodium Acetate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Gallium (68Ga) Gozetotide",
  "authorisation_numbers": [
    "BE664536"
  ]
}

See everything about gallium (68ga) gozetotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.